NCT04305756View on ClinicalTrials.gov

Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery

NACompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

June 12, 2020

Primary Completion Date

December 15, 2021

Study Completion Date

December 15, 2021

Conditions
ThromboembolismPostpartum DVTThrombosis
Interventions
DRUG

Enoxaparin

Low molecular weight heparin

Trial Locations (1)

84132

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT04305756 - Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery | Biotech Hunter | Biotech Hunter